{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:27:49Z","timestamp":1793262469589,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7519","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1038\/nature13775","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T11:21:06Z","timestamp":1410866466000},"page":"507-511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":209,"title":["Statin treatment rescues FGFR3 skeletal dysplasia phenotypes"],"prefix":"10.1038","volume":"513","author":[{"given":"Akihiro","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Yahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Sawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Ikegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Tsumaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,17]]},"reference":[{"key":"BFnature13775_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/371252a0","volume":"371","author":"F Rousseau","year":"1994","unstructured":"Rousseau, F. et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371, 252\u2013254 (1994)","journal-title":"Nature"},{"key":"BFnature13775_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","volume":"78","author":"R Shiang","year":"1994","unstructured":"Shiang, R. et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78, 335\u2013342 (1994)","journal-title":"Cell"},{"key":"BFnature13775_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/ajmg.a.33909","volume":"155","author":"ML Warman","year":"2011","unstructured":"Warman, M. L. et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am. J. Med. Genet. A. 155, 943\u2013968 (2011)","journal-title":"Am. J. Med. Genet. A."},{"key":"BFnature13775_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","volume":"84","author":"C Deng","year":"1996","unstructured":"Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. & Leder, P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911\u2013921 (1996)","journal-title":"Cell"},{"key":"BFnature13775_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MOP.0b013e32833b7a69","volume":"22","author":"MB Laederich","year":"2010","unstructured":"Laederich, M. B. & Horton, W. A. Achondroplasia: pathogenesis and implications for future treatment. Curr. Opin. Pediatr. 22, 516\u2013523 (2010)","journal-title":"Curr. Opin. Pediatr."},{"key":"BFnature13775_CR6","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1210\/en.2008-1676","volume":"150","author":"A Yasoda","year":"2009","unstructured":"Yasoda, A. et al. Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias. Endocrinology 150, 3138\u20133144 (2009)","journal-title":"Endocrinology"},{"key":"BFnature13775_CR7","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.10.014","volume":"91","author":"F Lorget","year":"2012","unstructured":"Lorget, F. et al. Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia. Am. J. Hum. Genet. 91, 1108\u20131114 (2012)","journal-title":"Am. J. Hum. Genet."},{"key":"BFnature13775_CR8","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1093\/hmg\/dds181","volume":"21","author":"Y Xie","year":"2012","unstructured":"Xie, Y. et al. Intermittent PTH (1\u201334) injection rescues the retarded skeletal development and postnatal lethality of mice mimicking human achondroplasia and thanatophoric dysplasia. Hum. Mol. Genet. 21, 3941\u20133955 (2012)","journal-title":"Hum. Mol. Genet."},{"key":"BFnature13775_CR9","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1093\/hmg\/dds390","volume":"21","author":"M Jin","year":"2012","unstructured":"Jin, M. et al. A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia. Hum. Mol. Genet. 21, 5443\u20135455 (2012)","journal-title":"Hum. Mol. Genet."},{"key":"BFnature13775_CR10","first-page":"203ra124","volume":"5","author":"S Garcia","year":"2013","unstructured":"Garcia, S. et al. Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice. Sci. Transl Med. 5, 203ra124 (2013)","journal-title":"Sci. Transl Med."},{"key":"BFnature13775_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1128\/MCB.20.2.516-522.2000","volume":"20","author":"E Monsonego-Ornan","year":"2000","unstructured":"Monsonego-Ornan, E., Adar, R., Feferman, T., Segev, O. & Yayon, A. The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation. Mol. Cell. Biol. 20, 516\u2013522 (2000)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature13775_CR12","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","volume":"125","author":"MC Naski","year":"1998","unstructured":"Naski, M. C., Colvin, J. S., Coffin, J. D. & Ornitz, D. M. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125, 4977\u20134988 (1998)","journal-title":"Development"},{"key":"BFnature13775_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nature Methods 8, 409\u2013412 (2011)","journal-title":"Nature Methods"},{"key":"BFnature13775_CR14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nbt.1683","volume":"28","author":"RA Oldershaw","year":"2010","unstructured":"Oldershaw, R. A. et al. Directed differentiation of human embryonic stem cells toward chondrocytes. Nature Biotechnol. 28, 1187\u20131194 (2010)","journal-title":"Nature Biotechnol."},{"key":"BFnature13775_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1073\/pnas.2237184100","volume":"101","author":"JY Cho","year":"2004","unstructured":"Cho, J. Y. et al. Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia. Proc. Natl Acad. Sci. USA 101, 609\u2013614 (2004)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13775_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bone.2006.11.030","volume":"41","author":"D Harada","year":"2007","unstructured":"Harada, D. et al. Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLC\u03b3-activated STAT1. Bone 41, 273\u2013281 (2007)","journal-title":"Bone"},{"key":"BFnature13775_CR17","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.cellsig.2008.04.001","volume":"20","author":"C Guo","year":"2008","unstructured":"Guo, C. et al. Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasia. Cell. Signal. 20, 1471\u20131477 (2008)","journal-title":"Cell. Signal."},{"key":"BFnature13775_CR18","doi-asserted-by":"publisher","first-page":"e3961","DOI":"10.1371\/journal.pone.0003961","volume":"3","author":"P Krejci","year":"2008","unstructured":"Krejci, P. et al. Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage. PLoS ONE 3, e3961 (2008)","journal-title":"PLoS ONE"},{"key":"BFnature13775_CR19","doi-asserted-by":"publisher","first-page":"13007","DOI":"10.1074\/jbc.273.21.13007","volume":"273","author":"L Legeai-Mallet","year":"1998","unstructured":"Legeai-Mallet, L., Benoist-Lasselin, C., Delezoide, A. L., Munnich, A. & Bonaventure, J. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J. Biol. Chem. 273, 13007\u201313014 (1998)","journal-title":"J. Biol. Chem."},{"key":"BFnature13775_CR20","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1359\/jbmr.2003.18.8.1395","volume":"18","author":"Y Yamanaka","year":"2003","unstructured":"Yamanaka, Y., Tanaka, H., Koike, M., Nishimura, R. & Seino, Y. PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation. J. Bone Miner. Res. 18, 1395\u20131403 (2003)","journal-title":"J. Bone Miner. Res."},{"key":"BFnature13775_CR21","doi-asserted-by":"publisher","first-page":"990","DOI":"10.18632\/aging.100213","volume":"2","author":"K Yudoh","year":"2010","unstructured":"Yudoh, K. & Karasawa, R. Statin prevents chondrocyte aging and degeneration of articular cartilage in osteoarthritis (OA). Aging 2, 990\u2013998 (2010)","journal-title":"Aging"},{"key":"BFnature13775_CR22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jor.20953","volume":"28","author":"T Simopoulou","year":"2010","unstructured":"Simopoulou, T., Malizos, K. N., Poultsides, L. & Tsezou, A. Protective effect of atorvastatin in cultured osteoarthritic chondrocytes. J. Orthop. Res. 28, 110\u2013115 (2010)","journal-title":"J. Orthop. Res."},{"key":"BFnature13775_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10195-012-0200-4","volume":"13","author":"JF Baker","year":"2012","unstructured":"Baker, J. F., Walsh, P. M., Byrne, D. P. & Mulhall, K. J. Pravastatin suppresses matrix metalloproteinase expression and activity in human articular chondrocytes stimulated by interleukin-1\u03b2. J. Orthopaed. Traumatol. 13, 119\u2013123 (2012)","journal-title":"J. Orthopaed. Traumatol."},{"key":"BFnature13775_CR24","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","volume":"286","author":"G Mundy","year":"1999","unstructured":"Mundy, G. et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286, 1946\u20131949 (1999)","journal-title":"Science"},{"key":"BFnature13775_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1042\/CS20130332","volume":"126","author":"PJ Millar","year":"2014","unstructured":"Millar, P. J. & Floras, J. S. Statins and the autonomic nervous system. Clinical Sci. 126, 401\u2013415 (2014)","journal-title":"Clinical Sci."},{"key":"BFnature13775_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2174\/157016112799305076","volume":"10","author":"F Olivieri","year":"2012","unstructured":"Olivieri, F. et al. Telomere\/telomerase system: a new target of statins pleiotropic effect? Curr. Vasc. Pharmacol. 10, 216\u2013224 (2012)","journal-title":"Curr. Vasc. Pharmacol."},{"key":"BFnature13775_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.biocel.2012.11.001","volume":"45","author":"J Zhang","year":"2013","unstructured":"Zhang, J. et al. Statins, autophagy and cancer metastasis. Int. J. Biochem. Cell Biol. 45, 745\u2013752 (2013)","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFnature13775_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10821","volume":"482","author":"MA Israel","year":"2012","unstructured":"Israel, M. A. et al. Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells. Nature 482, 216\u2013220 (2012)","journal-title":"Nature"},{"key":"BFnature13775_CR29","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/S0140-6736(04)16513-6","volume":"363","author":"SM Wolfe","year":"2004","unstructured":"Wolfe, S. M. Dangers of rosuvastatin identified before and after FDA approval. Lancet 363, 2189\u20132190 (2004)","journal-title":"Lancet"},{"key":"BFnature13775_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1679\/aohc.66.123","volume":"66","author":"T Kawamoto","year":"2003","unstructured":"Kawamoto, T. Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants. Arch. Histol. Cytol. 66, 123\u2013143 (2003)","journal-title":"Arch. Histol. Cytol."},{"key":"BFnature13775_CR31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cryobiol.2008.12.011","volume":"58","author":"T Takeo","year":"2009","unstructured":"Takeo, T. et al. Birth of mice from vitrified\/warmed 2-cell embryos transported at a cold temperature. Cryobiology 58, 196\u2013202 (2009)","journal-title":"Cryobiology"},{"key":"BFnature13775_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul, F., Erdfelder, E., Lang, A. G. & Buchner, A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39, 175\u2013191 (2007)","journal-title":"Behav. Res. Methods"},{"key":"BFnature13775_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.joca.2010.11.007","volume":"19","author":"D Ikegami","year":"2011","unstructured":"Ikegami, D. et al. Identification of small molecular compounds and fabrication of its aqueous solution by laser-ablation, expanding primordial cartilage. Osteoarth. Cartil. 19, 233\u2013241 (2011)","journal-title":"Osteoarth. Cartil."},{"key":"BFnature13775_CR34","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nprot.2008.95","volume":"3","author":"M Gosset","year":"2008","unstructured":"Gosset, M., Berenbaum, F., Thirion, S. & Jacques, C. Primary culture and phenotyping of murine chondrocytes. Nature Protocols 3, 1253\u20131260 (2008)","journal-title":"Nature Protocols"},{"key":"BFnature13775_CR35","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1172\/JCI44605","volume":"121","author":"K Hiramatsu","year":"2011","unstructured":"Hiramatsu, K. et al. Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors. J. Clin. Invest. 121, 640\u2013657 (2011)","journal-title":"J. Clin. Invest."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature13775.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature13775","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature13775.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T11:19:51Z","timestamp":1717327191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature13775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":35,"journal-issue":{"issue":"7519","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["BFnature13775"],"URL":"https:\/\/doi.org\/10.1038\/nature13775","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"1 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}